Skip to main content
OpenTrials
Completed

NCT Number: NCT02567162

Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage

The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intracerebral Hemorrhage Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebral Hemorrhage Cerebrovascular Disorders Hemorrhage Hemorrhagic Stroke Intracranial Hemorrhages Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

MNEMONICH is a disease-specific registry of prospectively collected data obtained from the integration and harmonization of preexisting single-center data sets. It was formed to provide clinician-scientists around the world a comprehensive database to direct future studies toward better understanding of ICH. MNEMONICH will help examine global variability in the prevalence of ICH and identify research priorities.

New data for MNEMONICH will be prospectively collected on a wide range of features including demographics, medical history, dates and times of symptom onset, presentation symptoms, hemodynamic signs, initial and chronic medical therapy, diagnostic imaging, laboratory and genetic analyses, pathological data, and surgical and medical management. Future research will be based upon ad hoc analysis of this data.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria
  • Age 18 and above
  • Able to consent

Exclusion criteria

  • ICH due to trauma
  • ICH due to vascular malformation or aneurysm
  • ICH due to brain tumor
  • ICH due to underlying infectious lesion (e.g., abscess)

Treatment and study plan

Primary outcomes

  1. Modified Rankin Scale score

    Time frame: 90 days

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center at San Antonio

Other

Collaborators

  • Azienda USL Reggio Emilia - IRCCS
  • Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention
  • Hospital Interzonal de Agudos San Juan Bautista
  • Maastricht University Medical Center
  • Manchester Metropolitan University
  • Northern Care Alliance NHS Foundation Trust
  • San Camillo de' Lellis General Hospital
  • University of Central Florida
  • University of Manchester
  • University of Medicine and Pharmacy Craiova
  • University of Rostock
  • University of Western Ontario, Canada

Registry information

Official study title

Multinational Survey of Epidemiology, Morbidity, and Outcomes in Intracerebral Hemorrhage (MNEMONICH)

Acronym: MNEMONICH

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Oct 2, 2015
Registry last updated
Dec 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.